Boston Financial Management’s Marker Therapeutics MRKR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-6,105	Closed	-$206K	–	270
2018 Q1	$206K	Buy	+6,105	New	+$206K	0.01%	255